SR34006 (idraparinux sodium) Injection

DRUG2 trials

Sponsors

Sanofi

Conditions

Atrial FibrillationDeep Vein ThrombosisPulmonary Embolism

Phase 3

Evaluating the Use of SR34006 Compared to Warfarin or Acenocoumarol in Patients With Atrial Fibrillation (AMADEUS)

CompletedNCT00070655

SanofiAtrial Fibrillation

Start: 2003-09-30End: 2006-03-31Updated: 2011-04-06

SR34006 Compared to Placebo in Patients Who Have Completed 6 Months of Treatment for Symptomatic Pulmonary Embolism or Deep Vein Thrombosis

CompletedNCT00071279

SanofiDeep Vein Thrombosis, Pulmonary Embolism

Start: 2003-11-30End: 2005-12-31Updated: 2011-04-06

Related Papers

Scoring and psychometric validation of the Perception of Anticoagulant Treatment Questionnaire (PACT-Q).

2009-04-0751 citations

Comparison of idraparinux with vitamin K antagonists for prevention of thromboembolism in patients with atrial fibrillation: a randomised, open-label, non-inferiority trial.

2008-01-01176 citations

Extended prophylaxis of venous thromboembolism with idraparinux.

2007-09-0171 citations